Bayer Aktiengesellschaft Stock Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.23B 50.28B | Sales 2025 * | 48.12B 51.23B | Capitalization | 25.78B 27.44B |
---|---|---|---|---|---|
Net income 2024 * | 2.36B 2.51B | Net income 2025 * | 3.21B 3.41B | EV / Sales 2024 * | 1.24 x |
Net Debt 2024 * | 32.81B 34.93B | Net Debt 2025 * | 29.7B 31.62B | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
7.96
x | Employees | - |
Yield 2024 * |
1.31% | Yield 2025 * |
1.43% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
Director of Finance/CFO | 54 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Director/Board Member | 68 | 17-03-31 | |
Alberto Weisser
BRD | Director/Board Member | 67 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.81% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.11% | 211B | |
-0.49% | 203B | |
-10.06% | 194B | |
-11.81% | 144B |